Towards a holistic approach to pulmonary infections. Insights from the Sixth Annual Meeting of Spanish Experts 2024
Open Access
- 27 March 2025
- journal article
- review article
- Published by Sociedad Espanola de Quimioterapia in Revista Española de Quimioterapia
- Vol. 38 (3) , 152-186
Abstract
Pneumonia is the leading cause of death from infection in the developed world. In recent years, researchers and healthcare professionals have worked extensively to reduce this burden. Prevention is better than cure, and significant advances have been made in areas such as vaccination and the prevention of nosocomial pneumonia in intensive care units. Comprehensive surveillance programmes and new diagnostic methods have been developed to assess trends in this disease and to identify the infectious agents involved. Clinical presentation can be challenging in elderly patients or those with certain comorbidities, prompting new studies in these populations to address these issues. Correct and early management of severe community-acquired pneumonia represents a major opportunity to reduce its associated mortality. Although fungal pathogens are an uncommon cause of lung infection, they are associated with high morbidity and mortality, highlighting the need for new approaches. Finally, new drugs are available for the treatment of pneumonia, and a thorough understanding of them is key to ensuring their correct use, particularly to combat multi-resistance. To provide an update on these points, a multidisciplinary team of Spanish experts convened at the Sixth Annual Meeting of Pneumonia Day, under the scientific sponsorship of GEIPC-SEIMC. This paper reflects the information shared at this meeting, offering the latest insights on these topics and supporting a holistic approach to pneumonia management.Keywords
This publication has 286 references indexed in Scilit:
- Development and Validation of a Clinical Prediction Rule for Severe Community-acquired PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Antifungal Combination TherapyDrugs, 2005
- Plasma and lung concentrations of ceftazidime administered in continuous infusion to critically ill patients with severe nosocomial pneumoniaIntensive Care Medicine, 2004
- Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation studyThorax, 2003
- Procalcitonin as a marker of bacterial infectionThe Pediatric Infectious Disease Journal, 2000
- Bacteremic Pneumonia Due to Staphylococcus aureus: A Comparison of Disease Caused by Methicillin-Resistant and Methicillin-Susceptible OrganismsClinical Infectious Diseases, 1999
- A Prediction Rule to Identify Low-Risk Patients with Community-Acquired PneumoniaNew England Journal of Medicine, 1997
- Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patientsAntimicrobial Agents and Chemotherapy, 1993
- The effect of selective decontamination of the digestive tract on colonisation and infection rate in multiple trauma patientsIntensive Care Medicine, 1984